EA026750B1 - КРИСТАЛЛИЧЕСКИЙ (1R,4R)-6'-ФТОР-N,N-ДИМЕТИЛ-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН - Google Patents

КРИСТАЛЛИЧЕСКИЙ (1R,4R)-6'-ФТОР-N,N-ДИМЕТИЛ-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН Download PDF

Info

Publication number
EA026750B1
EA026750B1 EA201400120A EA201400120A EA026750B1 EA 026750 B1 EA026750 B1 EA 026750B1 EA 201400120 A EA201400120 A EA 201400120A EA 201400120 A EA201400120 A EA 201400120A EA 026750 B1 EA026750 B1 EA 026750B1
Authority
EA
Eurasian Patent Office
Prior art keywords
approximately
crystalline form
dimethyl
fluoro
pyrano
Prior art date
Application number
EA201400120A
Other languages
English (en)
Russian (ru)
Other versions
EA201400120A1 (ru
Inventor
Михаэль Грусс
Штефан Клуге
Штефан Прюс
Original Assignee
Грюненталь Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Грюненталь Гмбх filed Critical Грюненталь Гмбх
Publication of EA201400120A1 publication Critical patent/EA201400120A1/ru
Publication of EA026750B1 publication Critical patent/EA026750B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
EA201400120A 2011-07-08 2012-07-06 КРИСТАЛЛИЧЕСКИЙ (1R,4R)-6'-ФТОР-N,N-ДИМЕТИЛ-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН EA026750B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11005587 2011-07-08
PCT/EP2012/002839 WO2013007361A1 (en) 2011-07-08 2012-07-06 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Publications (2)

Publication Number Publication Date
EA201400120A1 EA201400120A1 (ru) 2014-06-30
EA026750B1 true EA026750B1 (ru) 2017-05-31

Family

ID=46717800

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400120A EA026750B1 (ru) 2011-07-08 2012-07-06 КРИСТАЛЛИЧЕСКИЙ (1R,4R)-6'-ФТОР-N,N-ДИМЕТИЛ-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН

Country Status (23)

Country Link
US (2) US8618156B2 (OSRAM)
EP (2) EP2729470B1 (OSRAM)
JP (2) JP6276689B2 (OSRAM)
CN (2) CN106939005A (OSRAM)
AR (1) AR087081A1 (OSRAM)
AU (2) AU2012283449B2 (OSRAM)
BR (1) BR112014000358A2 (OSRAM)
CA (1) CA2841032C (OSRAM)
CY (1) CY1120525T1 (OSRAM)
DK (2) DK3235821T3 (OSRAM)
EA (1) EA026750B1 (OSRAM)
ES (1) ES2641299T3 (OSRAM)
HR (1) HRP20170968T1 (OSRAM)
HU (1) HUE033043T2 (OSRAM)
IL (1) IL230331B (OSRAM)
LT (1) LT2729470T (OSRAM)
MX (1) MX2014000297A (OSRAM)
PL (1) PL2729470T3 (OSRAM)
PT (1) PT2729470T (OSRAM)
RS (1) RS56343B1 (OSRAM)
SI (1) SI2729470T1 (OSRAM)
TW (1) TWI585092B (OSRAM)
WO (1) WO2013007361A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2729470B1 (en) * 2011-07-08 2017-06-21 Grünenthal GmbH Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
US10022353B2 (en) * 2015-01-23 2018-07-17 Grünenthal GmbH Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function
ES2713960T3 (es) 2015-02-02 2019-05-24 Ratiopharm Gmbh Composición que comprende cebranopadol en forma disuelta
WO2017148595A1 (en) 2016-02-29 2017-09-08 Grünenthal GmbH Titration of cebranopadol
CN112313202A (zh) * 2019-05-21 2021-02-02 江苏众强药业有限公司 曲前列尼尔钠盐新晶型及制备方法
CN112254496A (zh) * 2020-09-25 2021-01-22 榆林学院 一种煤泥收集装置
WO2024129782A1 (en) 2022-12-12 2024-06-20 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain
EP4665333A1 (en) 2023-02-15 2025-12-24 Adneuris Therapeutics, Inc. Regimens and compositions useful for alleviating pain

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043967A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische cyclohexan-derivate
WO2006108565A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spirocyclishe cyclohexanderivate zur behandlung von substanzabhängigkeit
WO2008009415A2 (de) * 2006-07-18 2008-01-24 Grünenthal GmbH 4-heteroaryl-substituierte 1-aminocyclohexan-1- und cyclohexen-1-derivate mit wirkung auf das opiod rezeptor system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006046745A1 (de) 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
EP2600850B1 (en) * 2010-08-04 2018-10-17 Grünenthal GmbH Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
EP2729470B1 (en) * 2011-07-08 2017-06-21 Grünenthal GmbH Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043967A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische cyclohexan-derivate
WO2006108565A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spirocyclishe cyclohexanderivate zur behandlung von substanzabhängigkeit
WO2008009415A2 (de) * 2006-07-18 2008-01-24 Grünenthal GmbH 4-heteroaryl-substituierte 1-aminocyclohexan-1- und cyclohexen-1-derivate mit wirkung auf das opiod rezeptor system

Also Published As

Publication number Publication date
TW201311694A (zh) 2013-03-16
US20130231381A1 (en) 2013-09-05
LT2729470T (lt) 2017-08-25
JP2014518226A (ja) 2014-07-28
CN103649094A (zh) 2014-03-19
US20130012563A1 (en) 2013-01-10
MX2014000297A (es) 2014-01-31
CA2841032A1 (en) 2013-01-17
AR087081A1 (es) 2014-02-12
US8765800B2 (en) 2014-07-01
ES2641299T3 (es) 2017-11-08
WO2013007361A1 (en) 2013-01-17
AU2012283449A1 (en) 2014-02-20
JP6559165B2 (ja) 2019-08-14
BR112014000358A2 (pt) 2017-01-10
AU2017204572A1 (en) 2017-07-27
CN106939005A (zh) 2017-07-11
EP2729470B1 (en) 2017-06-21
EP2729470A1 (en) 2014-05-14
RS56343B1 (sr) 2017-12-29
EA201400120A1 (ru) 2014-06-30
CA2841032C (en) 2020-12-15
PT2729470T (pt) 2017-10-02
WO2013007361A8 (en) 2013-04-04
PL2729470T3 (pl) 2017-11-30
AU2012283449A8 (en) 2014-03-27
EP3235821A1 (en) 2017-10-25
WO2013007361A9 (en) 2013-12-27
JP2017081981A (ja) 2017-05-18
DK2729470T3 (en) 2017-09-11
HUE033043T2 (hu) 2017-11-28
AU2012283449B2 (en) 2017-04-06
CN103649094B (zh) 2017-05-24
DK3235821T3 (da) 2020-04-20
TWI585092B (zh) 2017-06-01
HRP20170968T1 (hr) 2017-09-22
SI2729470T1 (sl) 2017-10-30
EP3235821B1 (en) 2020-04-08
AU2017204572B2 (en) 2018-05-24
CY1120525T1 (el) 2019-07-10
JP6276689B2 (ja) 2018-02-07
IL230331B (en) 2018-11-29
US8618156B2 (en) 2013-12-31

Similar Documents

Publication Publication Date Title
EA026750B1 (ru) КРИСТАЛЛИЧЕСКИЙ (1R,4R)-6'-ФТОР-N,N-ДИМЕТИЛ-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН
JP2022140559A (ja) Ｒａｄ１９０１－２ｈｃｌの多形性形態
US12410189B2 (en) Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9- yl)amino)propanamide, and methods of production
EP1919893A2 (en) Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
EP2526101A1 (en) Crystalline forms of a purine derivative
KR20190140962A (ko) 오피오이드 수용체(mor) 작용제 염, 이의 푸마레이트 염 i 결정 형태 및 이의 제조 방법
WO2012156384A1 (en) Novel crystalline salts of asenapine
US20130123324A1 (en) Crystalline (1r, 4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
CA2858762C (en) Solid forms of (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine hydrochloride
JP2019517575A (ja) ナトリウム−グルコース共輸送体２阻害剤の結晶形
CN108473507A (zh) 噻吩并嘧啶化合物的结晶形式
TW201008935A (en) Crystalline forms of thiazolidinedione compound and its manufacturing method
TW202016099A (zh) 一種鴉片類物質受體激動劑的結晶形式及製備方法
EA029975B1 (ru) ТВЕРДЫЕ ФОРМЫ (1r,4r)-6'-ФТОР-(N,N-ДИМЕТИЛ)-4-ФЕНИЛ-4'9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИНА И СЕРНОЙ КИСЛОТЫ
RU2779119C2 (ru) Соль агониста опиоидного рецептора (mor), кристаллическая форма i его фумаратной соли и способ их получения
HK1195900A (en) Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
HK1195900B (en) Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU